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Abstract We used comparative genomics and experimental analyses to show that (1)
eukaryotes and archaea, which possess the selenocysteine (Sec) protein insertion machinery
contain an enzyme, O-phosphoseryl-transfer RNA (tRNA)[Ser]Sec kinase (designated
PSTK), which phosphorylates seryl-tRNA[Ser]Sec to form O-phosphoseryl-tRNA[Ser]Sec
and (2) the Sec synthase (SecS) in mammals is a pyridoxal phosphate-containing protein
previously described as the soluble liver antigen (SLA). SecS uses the product of PSTK, O-
phosphoseryl-tRNA[Ser]Sec, and selenophosphate as substrates to generate selenocysteyl-
tRNA[Ser]Sec. Sec could be synthesized on tRNA[Ser]Sec from selenide, adenosine triphosphate
(ATP), and serine using tRNA[Ser]Sec, seryl-tRNA synthetase, PSTK, selenophosphate
synthetase, and SecS. The enzyme that synthesizes monoselenophosphate is a previously
identified selenoprotein, selenophosphate synthetase 2 (SPS2), whereas the previously
identified mammalian selenophosphate synthetase 1 did not serve this function.
Monoselenophosphate also served directly in the reaction replacing ATP, selenide, and
SPS2, demonstrating that this compound was the active selenium donor. Conservation of the
overall pathway of Sec biosynthesis suggests that this pathway is also active in other
eukaryotes and archaea that contain selenoproteins.
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Introduction
The selenium field has grown at a rapid pace over the last 15 to 20 years, and many new
developments have occurred recently in the biochemistry and genetic areas of selenium
research. Several thorough reviews have covered these topics [1–4]. Herein, we have
focused on recent developments involving the biosynthesis of selenocysteine (Sec) in
eukaryotes and archaea that have not been reviewed elsewhere.
Sec is the 21st amino acid in the genetic code. It is cotranslationally inserted into protein
in response to the codon, UGA [1–4]. The biosynthesis of Sec occurs on its transfer RNA
(tRNA), and the pathway begins with the initial aminoacylation of Sec tRNAwith serine [5,
6]. Thus, the backbone for Sec is serine, and the identity elements in Sec tRNA for its
aminoacylation correspond to those in seryl-tRNA synthetase [7, 8]. Sec tRNA has
therefore been appropriately designated Sec tRNA[Ser]Sec [9]. Although the biosynthetic
pathway for Sec was established in eubacteria more than 15 years ago [10–12], only
recently was the complete pathway for the biosynthesis of this amino acid elucidated in
eukaryotes [13]. In Escherichia coli, the enzyme that synthesizes Sec, Sec synthase (SelA),
was identified in the early 1990s and is a pyridoxal phosphate (PLP)-dependent protein
[10–12]. SelA acts on the serine moiety attached to Sec tRNA[Ser]Sec by initially removing
the hydroxyl group from serine to generate aminoacrylyl as an intermediate. Aminoacrylyl
then accepts activated selenium to form selenocysteyl-tRNA[Ser]Sec. The activated selenium
in bacteria is monoselenophosphate, and it is synthesized from selenide and adenosine
triphosphate (ATP) by E. coli selenophosphate synthetase (SelD) [14].
Several factors were previously characterized in higher vertebrates that were found to
have a role in Sec biosynthesis. For example, a kinase that phosphorylated a minor seryl-
tRNA to form O-phosphoseryl-tRNA was reported in rooster liver as early as 1970 [15].
This same year a minor seryl-tRNA from mammalian and chicken liver was found to
decode specifically the termination codon, UGA [16], which was subsequently shown to be
the same tRNA that formed phosphoseryl-tRNA [17]. This tRNA was subsequently
identified as Sec tRNA[Ser]Sec [6]. The kinase, designated O-phosphoseryl-tRNA[Ser]Sec
kinase (PSTK), was recently isolated, characterized, and found to specifically
phosphorylate the seryl moiety on seryl-tRNA[Ser]Sec [18]. The resulting O-phosphoseryl-
tRNA[Ser]Sec product had been proposed as an intermediate in the biosynthesis of Sec [3,
18]. In addition, because no sequences with homology to SelA could be detected in
eukaryotes, there was some question as to the identity of the Sec synthase (SecS) in
mammals. The soluble liver antigen (SLA), which was initially identified as a 48-kDa
protein bound to Sec tRNA[Ser]Sec and was targeted by antibodies in patients with an
autoimmune chronic hepatitis [19], was reported to occur as a separate family within a
larger superfamily of diverse PLP-dependent transferases [20] and proposed as a possible
SecS in mammals [3, 20–22]. SLA was also found to exist in a protein complex with other
factors involved in Sec biosynthesis and/or its insertion into protein providing further
evidence that this protein is involved in selenium metabolism [22, 23]. As described herein,
SLA is indeed SecS in mammals [13]. In addition, two genes, sps1 and sps2, were found
that had homology to SelD and the products of both genes were initially proposed to serve
as selenophosphate synthetase (SPS) in mammals [24–27]. Interestingly, sps2 encodes a
selenoprotein, SPS2, which can serve, provided it is responsible for making the active
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selenium donor for the biosynthesis of Sec, as an autoregulator of selenoprotein synthesis
[24, 26]. The Sec moiety in SPS2 was mutated to Cys, and the mutant has low enzyme
activity [24, 26, 28], but is capable of complementing SelD− E. coli cells transfected with
the mammalian mutant form [28]. Additional studies involving the complementation of
SelD− E. coli cells with either SPS2 or SPS1 suggested that SPS2 is involved in the synthesis of
selenophosphate, whereas SPS1 has a role in recycling Sec via a selenium salvage pathway [29].
We used a computational, comparative genomics approach to identify a single kinase
with homologies common only to archaea and eukaryotes that utilize the Sec protein
insertion machinery [18]. We also used a similar comparative genomics approach to
identify SLA as the likely SecS [13]. These two studies demonstrate the potential of
scanning even very distantly related genomes for new metabolic enzymes and the value
of interdisciplinary research.
Each of the components discussed above, including tRNA[Ser]Sec, seryl-tRNA[Ser]Sec,
O-phosphoseryl-tRNA[Ser]Sec, seryl-tRNA[Ser]Sec synthetase, PSTK, SLA, SPS2, and
selenophosphate, finally were used to establish the biosynthetic pathway of the 21st amino
acid in the genetic code in eukaryotes [13]. The fact that both SLA and PSTK sequences are
found in eukaryotes and archaea that utilize the Sec protein insertion machinery, but not in
those organisms that do not, provide strong evidence that this pathway is used by all
eukaryotes and archaea that synthesize Sec-containing proteins ([13, 18] and also see [30]).
Discussion
Identifying Sec Kinase
We initially hypothesized that the pathway for synthesizing Sec was the same in those
eukaryotes and archaea-making selenoproteins and that O-phosphoseryl-tRNA was a
common intermediate [18]. Therefore, we compared the genomes of the two archaea that
encode the Sec protein insertion machinery, Methanopyrus kandleri and Methanococccus
jannaschii, to the 12 archaea whose genomes have been sequenced and do not encode the
Sec insertion machinery for kinase-like genes using the BLASTN program [18]. There were
two candidates found in the two archaea using Sec insertion machinery and not in the 12 other
archaea. Interestingly, only one of these two protein genes, a predicted nucleotide kinase (gi:
20095115), had homologous sequences in eukaryotes encoding the Sec insertion machinery,
but not in those eukaryotes whose genomes had been sequenced and lacked the Sec insertion
machinery. The corresponding putative kinase gene (pstk) from mice was cloned into an
expression vector, expressed, and the product purified and characterized [18]. The pstk
coding sequence is 1,080 nucleotides that encodes a 359 amino acid protein. The resulting
protein generated from the cloned expression vector used the serylated forms of mcm5U
and mcm5Um as substrates to yield O-phosphoseryl-tRNA[Ser]Sec. In addition to these two
serylated isoforms, PSTK requires ATP and Mg++, and the reaction may be summarized as
follows:
(PSTK + Mg++) 
Seryl-tRNA[Ser]Sec + ATP               O-phosphoseryl-tRNA[Ser]Sec + ADP 
Even after the identification and characterization of PSTK [18], its function was
uncertain, as this kinase had been proposed to provide either a storage form of Sec
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tRNA[Ser]Sec [31] or the intermediate in Sec biosynthesis [3, 18]. This issue was not
resolved until the entire biosynthetic pathway of Sec was determined as described below.
Identifying SecS
The genomes of eukaryotes and archaea that had been completely sequenced were analyzed
for the occurrence of selenoproteins, and comparative genomics studies were carried out to
identify genes that co-occur with selenoproteins in these organisms [13]. Each search resulted
in known components of the Sec insertion machinery and an additional protein that might be
SecS in mammals. This additional protein had previously been detected in patients with
autoimmune chronic hepatitis as an autoimmune factor that co-precipitated tRNA[Ser]Sec in
cell extracts of these individuals and was known as the SLA [19]. SLA, which is a PLP-
dependent transferase [20], also bound other protein components involved with Sec
metabolism [22, 23]. We found that SLA occurred in all eukaryotes and archaea-encoding
selenoproteins, but not in those organisms examined that lacked selenoproteins. These and
other observations strongly suggested that SLA was the missing SecS in eukaryotes and
archaea and that SelA from eubacteria and this potential SecS belonged to totally different
families of PLP-containing proteins suggesting that their similar functions arose by
convergent evolution [13].
After identifying a potential SecS candidate by comparative genomics analysis as des-
cribed above, we examined its function experimentally. The putative mouse SecS (mSecS)
gene was cloned and expressed, and the binding of O-phosphoseryl-tRNA[Ser]Sec, seryl-
tRNA[Ser]Sec and tRNA[Ser]Sec, and seryl-tRNASer and tRNASer as controls, to the expressed
product were examined. The efficiency of binding was O-phosphoseryl-tRNA[Ser]Sec >
tRNA[Ser]Sec > seryl-tRNA[Ser]Sec, whereas seryl-tRNASer and tRNASer did not bind at all.
These results suggested that O-phosphoseryl-tRNA[Ser]Sec is a substrate for mSecS. We next
tested whether mSecS would remove the phosphate from the O-phosphoseryl moiety and
found that it was rapidly dephosphorylated. The dephosphorylated product is likely not
seryl-tRNA[Ser]Sec, as the product bound efficiently to mSecS, but seryl-tRNA[Ser]Sec did not.
Although these experiments suggested that mSecS was the mammalian SecS, it was essential
to determine that the dephosphorylated product would accept the active selenium donor to
form Sec before it could be concluded that mouse SLA was indeed the true Sec synthase in
mammals. We therefore turned our attention to examining the functions of the two SPS,
SPS1 and SPS2, to determine if either, or both, could produce the active selenium donor.
Identifying a Functional SPS in Mammals
To identify the active selenium donor, mouse sps1 (msps1) and sps2 (msps2) were indi-
vidually cloned into an expression vector, and the Sec codon in msps2 converted to a Cys
codon (msps2-Cys) [13]. Furthermore, because Caenorhabditis elegans sps2 (csps2)
naturally encodes Cys at the active site in place of Sec found in mammals, csps2 was
also cloned. We expressed msps1, msps2-Cys, csps2, and E. coli selD, purified the products,
and assessed their abilities to synthesize monoselenophosphate (SeP) because, as noted in
“Introduction,” SeP is synthesized by SelD and had been identified as the active selenium
donor in E. coli [10–12]. Each of these proteins was incubated separately with ATP and
selenite under anaerobic conditions and a 31P NMR spectrophotometric analysis of the
products carried out. The mSPS2-Cys, cSPS2, and SelD reactions produced a signal at
+23.2 ppm that corresponded to SeP, but interestingly, mSPS1 did not. These data provide
strong evidence that the eukaryotic SPS2s synthesize SeP, as does SelD, but SPS1 does not.
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Sec Biosynthesis (In Vitro)
As previous studies analyzing Sec biosynthesis had not determined whether SeP could
serve directly as the selenium donor [10–12], we chemically synthesized this compound
and used it in in vitro reactions. Reactions containing SeP and O-phosphoseryl-tRNA[Ser]Sec
incubated in the presence of mSecS did indeed produce Sec. Control assays containing
seryl-tRNA[Ser]Sec in place of O-phosphoseryl-tRNA[Ser]Sec, without SeP or containing
another protein in place of mSecS, did not form Sec. These studies unequivocally
demonstrated that SeP is the active selenium donor in Sec biosynthesis in which SLA is the
missing SecS and O-phosphoseryl-tRNA[Ser]Sec is a true intermediate in the Sec biosynthetic
pathway [13].
Although, as noted above, SPS2 was capable of producing SeP in reactions with ATP
and selenide, whereas SPS1 was not, it was important to demonstrate whether Sec could be
produced on its tRNA in reactions with these components and O-phosphoseryl-tRNA[Ser]Sec
and SecS. Incubation of mSecS, O-phosphoseryl-tRNA[Ser]Sec, mSPS2, selenide, and ATP
produced Sec. However, replacement of mSecS with mSPS1 or O-phosphoseryl-tRNA[Ser]Sec
with seryl-tRNA[Ser]Sec did not generate Sec. These studies demonstrate unequivocally that
SPS2 synthesizes the active selenium donor for Sec synthesis and that SPS1 likely has
another role in selenium metabolism. It is of interest to note that we also observed that SelA
could use either seryl-tRNA[Ser]Sec or phosphoseryl-tRNA[Ser]Sec as a substrate to produce
Sec in the presence of either SeP.
The intermediate generated by SelA action on seryl-tRNA[Ser]Sec has been identified as
dehydroalanyl-tRNA[Ser]Sec [10–12]. Although we did not identify the intermediate
synthesized by the dephosphorylation of O-phosphoseryl-tRNA[Ser]Sec by mSecS, the
available evidence suggested that it also was dehydroalanyl-tRNA[Ser]Sec [13].
Sec Biosynthesis (In Vivo)
A previous study had established SPS1 as a mammalian SPS [27], whereas another report
had suggested that SPS1 utilized free Sec for the biosynthesis of selenoproteins [29]. Our
in vitro studies described above, however, demonstrated that SPS2 is responsible for
synthesizing SeP, whereas SPS1 likely has another role in selenium metabolism. To resolve
these discrepancies between the earlier work [27, 29] and our more recent work [13] and to
further elucidate the roles of SPS1 and SPS2 in vivo, we used RNAi technology to
Sec
PPi
AMP + Pi
SeP
ATP
SPS2
HSe-
SecS
ADP
PSTK
ATP
Ser
SerS
+ ATP
AMP+PPi
Ser
tRNA[Ser]Sec
PSer
Fig. 1 The Sec biosynthetic pathway in eukaryotes. Abbreviations are defined in the text with the exception
of SerS, which is seryl-tRNA synthetase
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knockdown SPS1 and SPS2 intracellularly and examine the effect(s) of their targeted
removal on selenoprotein synthesis [32]. Knockdown of SPS2 in NIH3T3 cells obliterated
selenoprotein synthesis, whereas knockdown of SPS1 had no affect. We then used the
knockdown cells to transfect them with SPS2 or SPS1 and found that SPS2 or SelD
complemented the function of the removed SPS2, but SPS1 did not. These in vivo studies
demonstrated that SPS2, which synthesizes SeP [13] is essential for selenoprotein synthesis
and that SPS1 likely has a more specialized function in selenium metabolism [32].
The Sec Biosynthetic Pathway
The entire biosynthetic pathway of Sec in eukaryotes is shown in Fig. 1. tRNA[Ser]Sec is
initially aminoacylated with serine by seryl-tRNA synthetase [5, 6]. The seryl moiety is
then phosphorylated by PSTK to form O-phosphoseryl-tRNA[Ser]Sec [18]. O-phosphoseryl-
tRNA[Ser]Sec is the substrate for SecS, which in turn hydrolyzes the phosphate group to form
the acceptor molecule for SeP, and the latter reaction, which is also carried out by SecS,
yields Sec. SPS2 generates the active selenium donor, SeP, from selenide and ATP [13].
The kinase, PSTK, is not found in eubacteria, but interestingly, SelA can use O-
phosphoseryl-tRNA[Ser]Sec as a substrate. The major difference in the biosynthesis of Sec in
eubacteria and the pathway described herein in eukaryotes is the extra step involving O-
phosphoseryl-tRNA[Ser]Sec synthesis, which is a substrate for SecS [13, 30], whereas seryl-
tRNA is the substrate for SelA in E. coli.
Concluding Remarks
The biosynthesis of Sec, (1) from the initial step involving the aminoacylation of tRNA[Ser]Sec
with serine by seryl-tRNA synthetase (2) through its phosphorylation by PSTK to form O-
phosphoseryl-tRNA[Ser]Sec, (3) subsequent dephosphorylation of O-phosphoseryl-
tRNA[Ser]Sec to yield the acceptor molecule for SeP, (4) that in turn forms Sec wherein
the last two steps are carried out by SecS, has been deciphered in mammals (Fig. 1). We
also determined that SeP is synthesized by SPS2 and not by SPS1. These findings
demonstrate how selenium, an essential micronutrient in the diet of humans and other
mammals, becomes a component of Sec for its incorporation into protein in eukaryotes
and archaea. Selenoproteins are thought to be responsible for most of the health benefits
of selenium, which include preventing cancer and heart disease, delaying the aging
process and the onset of AIDS in HIV positive patients, and roles in development and
immune function [4].
Acknowledgements This research was supported by the Intramural Research Program of the National
Institutes of Health, National Cancer Institute, and Center for Cancer Research, by grants GM061603,
GM065204, and CA080946 to VNG, grants DK47320 and DK52963 to MJB, and grant CA-41108 (NIH
Colon Cancer Prevention Program Project) to RSG.
References
1. Birringer M, Pilawa S, Flohe L (2002) Trends in selenium biochemistry. Nat Prod Rep 19:693–718
2. Driscoll DM, Copeland PR (2003) Mechanism and regulation of selenoprotein synthesis. Annu Rev Nutr
23:17–40
Selenocysteine Biosynthesis 239
3. Hatfield DL, Carlson BA, Xu XM, Mix H, Gladyshev VN (2006) Selenocysteine incorporation
machinery and the role of selenoproteins in development and health. Prog Nucleic Acid Res Mol Biol
81:97–142
4. Hatfield DL, Berry MJ, Gladyshev VN, Eds (2006) Selenium: its molecular biology and role in human
health. Springer
5. Leinfelder W, Stadtman TC, Bock A (1989) Occurrence in vivo of selenocysteyl-tRNA(SERUCA) in
Escherichia coli. Effect of sel mutations. J Biol Chem 264:9720–9723
6. Lee BJ, Worland PJ, Davis JN, Stadtman TC, Hatfield DL (1989) Identification of a selenocysteyl-tRNA
(Ser) in mammalian cells that recognizes the nonsense codon, UGA. J Biol Chem 264:9724–9727
7. Wu XQ, Gross HJ (1993) The long extra arms of human tRNA([Ser]Sec) and tRNA(Ser) function as
major identify elements for serylation in an orientation-dependent, but not sequence-specific manner.
Nucleic Acids Res 21:5589–5594
8. Ohama T, Yang DC, Hatfield DL (1994) Selenocysteine tRNA and serine tRNA are aminoacylated by
the same synthetase, but may manifest different identities with respect to the long extra arm. Arch
Biochem Biophys 315:293–301
9. Hatfield DL, Choi IS, Ohama T, Jung JE, Diamond AM (1994) Selenocysteine tRNA(Ser)sec
isoacceptors as central components in selenoprotein biosynthesis in eukaryotes. In: Burk RF (ed)
Selenium in biology and human health. Springer, New York, NY, pp 25–44
10. Forchhammer K, Leinfelder W, Boesmiller K, Veprek B, Bock A (1991) Selenocysteine synthase from
Escherichia coli. Nucleotide sequence of the gene (selA) and purification of the protein. J Biol Chem
266:6318–6323
11. Forchhammer K, Boesmiller K, Bock A (1991) The function of selenocysteine synthase and SELB in the
synthesis and incorporation of selenocysteine. Biochimie 73:1481–1486
12. Forchhammer K, Bock A (1991) Selenocysteine synthase from Escherichia coli. Analysis of the reaction
sequence. J Biol Chem 266:6324–6328
13. Xu XM, Carlson BA, Mix H et al (2007) Biosynthesis of selenocysteine on Its tRNA in Eukaryotes.
PLoS Biol 5:96–105
14. Glass RS, Singh WP, Jung W, Veres Z, Scholz TD, Stadtman TC (1993) Monoselenophosphate:
synthesis, characterization, and identity with the prokaryotic biological selenium donor, compound
SePX. Biochemistry 32:12555–12559
15. Maenpaa PH, Bernfield MR (1970) A specific hepatic transfer RNA for phosphoserine. Proc Natl Acad
Sci U S A 67:688–695
16. Hatfield DL, Portugal FH (1970) Seryl-tRNA in mammalian tissues: chromatographic differences in
brain and liver and a specific response to the codon, UGA. Proc Natl Acad Sci U S A 67:1200–1206
17. Hatfield DL, Diamond AM, Dudock B (1982) Opal suppressor serine tRNAs from bovine liver form
phosphoseryl-tRNA. Proc Natl Acad Sci U S A 79:6215–6219
18. Carlson BA, Xu XM, Kryukov GV et al (2004) Identification and characterization of phosphoseryl-
tRNA[Ser]Sec kinase. Proc Natl Acad Sci U S A 101:12848–12853
19. Gelpi C, Sontheimer EJ, Rodriguez-Sanchez JL (1992) Autoantibodies against a serine tRNA-protein
complex implicated in cotranslational selenocysteine insertion. Proc Natl Acad Sci U S A 89:9739–9743
20. Kernebeck T, Lohse AW, Grotzinger J (2001) A bioinformatical approach suggests the function of the
autoimmune hepatitis target antigen soluble liver antigen/liver pancreas. Hepatology 34:230–233
21. Allmang C, Krol A (2006) Selenoprotein synthesis: UGA does not end the story. Biochimie 88:1561–1571
22. Small-Howard A, Morozova N, Stoytcheva Z et al (2006) Supramolecular complexes mediate
selenocysteine incorporation in vivo. Mol Cell Biol 26:2337–2346
23. Xu XM, Mix H, Carlson BA et al (2005) Evidence for direct roles of two additional factors, SECp43 and
soluble liver antigen, in the selenoprotein synthesis machinery. J Biol Chem 280:41568–41575
24. Guimaraes MJ, Peterson D, Vicari A et al (1996) Identification of a novel selD homolog from
eukaryotes, bacteria, and archaea: is there an autoregulatory mechanism in selenocysteine metabolism?
Proc Natl Acad Sci U S A 93:15086–15091
25. Kim IY, Stadtman TC (1995) Selenophosphate synthetase: detection in extracts of rat tissues by
immunoblot assay and partial purification of the enzyme from the archaean Methanococcus vannielii.
Proc Natl Acad Sci U S A 92:7710–7713
26. Kim IY, Guimaraes MJ, Zlotnik A, Bazan JF, Stadtman TC (1997) Fetal mouse selenophosphate
synthetase 2 (SPS2): characterization of the cysteine mutant form overproduced in a baculovirus-insect
cell system. Proc Natl Acad Sci U S A 94:418–421
27. Low SC, Harney JW, Berry MJ (1995) Cloning and functional characterization of human
selenophosphate synthetase, an essential component of selenoprotein synthesis. J Biol Chem
270:21659–21664
240 Xu et al.
28. Kim TS, Yu MH, Chung YW et al (1999) Fetal mouse selenophosphate synthetase 2 (SPS2): biological
activities of mutant forms in Escherichia coli. Mol Cells 9:422–428
29. Tamura T, Yamamoto S, Takahata M et al (2004) Selenophosphate synthetase genes from lung
adenocarcinoma cells: Sps1 for recycling L-selenocysteine and Sps2 for selenite assimilation. Proc Natl
Acad Sci U S A 101:16162–16167
30. Yuan J, Palioura S, Salazar JC et al (2006) RNA-dependent conversion of phosphoserine forms
selenocysteine in eukaryotes and archaea. Proc Natl Acad Sci U S A 103:18923–18927
31. Amberg R, Mizutani T, Wu XQ, Gross HJ (1996) Selenocysteine synthesis in mammalia: an identity
switch from tRNA(Ser) to tRNA(Sec). J Mol Biol 263:8–19
32. Xu X-M, Carlson BA, Irons R, Mix H, Zhong N, Gladyshev VN, Hatfield DL (2007) Selenophosphate
synthetase 2 is essential for selenoprotein biosynthesis. Biochem J 404:115–120
Selenocysteine Biosynthesis 241
